DNA X, Inc. (SONM) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$23.53M | -177.2% |
| 2024 | -$8.49M | -109.4% |
| 2023 | -$4.05M | +67.2% |
| 2022 | -$12.36M | +67.9% |
| 2021 | -$38.48M | -264.4% |
| 2020 | -$10.56M | +68.5% |
| 2019 | -$33.52M | -968.2% |
| 2018 | $3.86M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$23.53M | -177.2% |
| 2024 | -$8.49M | -109.4% |
| 2023 | -$4.05M | +67.2% |
| 2022 | -$12.36M | +67.9% |
| 2021 | -$38.48M | -264.4% |
| 2020 | -$10.56M | +68.5% |
| 2019 | -$33.52M | -968.2% |
| 2018 | $3.86M | — |